- SG$21.64m
- -SG$3.04m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.32 | ||
| Price to Tang. Book | 0.32 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -9.34% | ||
| Return on Equity | -2.3% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Dec | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SG$m | 30.94 | 37.94 | n/a | n/a | n/a | n/a | n/a | -100% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +90.8 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
UpHealth Group Limited, formerly Don Agro International Limited, is a Singapore-based company. The Company is focused on the healthcare sector. Its healthcare assets include Uni Medica, a large multifunctional medical facility with a gross floor area of approximately 7,000 square meters. Its Euroonco, a network of specialist oncology clinics specializing in the treatment of advanced stages of cancer, comprises three clinics located in major cities, with inpatient facilities, intensive care units and operating rooms, and with a total inpatient capacity of approximately 60 beds.
Directors
- Last Annual
- December 31st, 2025
- Last Interim
- December 31st, 2025
- Incorporated
- October 16th, 2018
- Public Since
- February 14th, 2020
- Sector
- Holding Companies
- Industry
- Financials
- Exchange
Singapore Exchange Securities Trading Ltd- Shares in Issue
- 150,272,700
- Address
- 10 Collyer Quay, #10-01, 049315
- Web
- http://donagroint.com
- Phone
- +65 65312266
- Auditors
- Foo Kon Tan LLP
Upcoming Events for GRQ
Half Year 2026 UpHealth Group Ltd Earnings Release
Similar to GRQ
Pacific Century Regional Developments
Singapore Exchange Securities Trading Ltd
FAQ
What is the UpHealth share price?
As of Today at 22:54 UTC, shares in UpHealth are trading at SG$0.14. This share price information is delayed by 15 minutes.
How has the UpHealth share price performed this year?
Shares in UpHealth last closed at SG$0.14 and the price had moved by -15.29% over the past 365 days. In terms of relative price strength the UpHealth share price has underperformed the FTSE Developed Asia Pacific Index by -44.3% over the past year.
What are the analyst and broker recommendations for UpHealth?
The overall consensus recommendation for UpHealth is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the UpHealth dividend yield?
UpHealth does not currently pay a dividend.
Does UpHealth pay a dividend?
UpHealth does not currently pay a dividend.
When does UpHealth next pay dividends?
UpHealth does not currently pay a dividend.
How do I buy UpHealth shares?
To buy shares in UpHealth you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of UpHealth?
As of the previous close price of SG$0.14, shares in UpHealth had a market capitalisation of SG$21.64m.
Where are UpHealth shares listed?
Here are the trading details for UpHealth:
- Country of listing: Singapore
- Exchange: SES
- Ticker Symbol: GRQ
What kind of share is UpHealth?
Based on an overall assessment of its quality, value and momentum UpHealth is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a UpHealth share price forecast for 2026?
The analyst consensus target price for shares in UpHealth is SG$0.64. That is 344.44% above the last closing price of SG$0.14.
Analysts covering UpHealth currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreWhat is the trend in the UpHealth share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like UpHealth. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -26.45%.
As of the last closing price of SG$0.14, shares in UpHealth were trading -24.89% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the UpHealth PE Ratio?
The UpHealth PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SG$0.14.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of UpHealth?
We do not have data on UpHealth's directors